AES (AES) closed the last trading session at $10.44, gaining 2.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $14.27 indicates a 36.7% upside potential. According to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that ...

Core Viewpoint - Camden National (CAC) shares have increased by 7.8% over the past four weeks, closing at $39.36, with a potential upside indicated by Wall Street analysts' price targets suggesting a mean estimate of $50.25, representing a 27.7% upside [1] Price Targets and Analyst Consensus - The average price targets range from a low of $47 to a high of $53, with a standard deviation of $3.20, indicating a relatively tight clustering of estimates. The lowest estimate suggests a 19.4% increase, while the highest points to a 34.7% upside [2] - A low standard deviation signifies strong agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research into fundamental drivers [9] Earnings Estimates and Analyst Optimism - Analysts show strong agreement in revising earnings per share (EPS) estimates higher, which correlates with potential stock price increases. The Zacks Consensus Estimate for the current year has risen by 0.6% over the past month, with one estimate increasing and no negative revisions [11][12] - CAC holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential for upside in the near term [13]

Group 1 - Five9 (FIVN) shares have increased by 15.3% over the past four weeks, closing at $24.83, with a mean price target of $39.50 indicating a potential upside of 59.1% [1] - The average of 20 short-term price targets ranges from a low of $23 to a high of $67, with a standard deviation of $12.03, suggesting variability in analyst estimates [2] - There is strong agreement among analysts regarding FIVN's ability to report better earnings than previously predicted, which supports the potential for stock upside [4][11] Group 2 - Over the last 30 days, eight earnings estimates for FIVN have been revised higher, resulting in a Zacks Consensus Estimate increase of 45.9% [12] - FIVN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for near-term upside [13] - While consensus price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [13]

Group 1 - Inspire Medical Systems (INSP) has shown a significant price increase of 14.5% over the past four weeks, with a mean price target of $225.07 indicating a potential upside of 39% from the current price of $161.88 [1] - The average of 15 short-term price targets ranges from a low of $175 to a high of $270, with a standard deviation of $26.91, suggesting a variability in analysts' estimates [2] - Analysts have revised earnings estimates higher, with seven estimates moving up in the last 30 days and no negative revisions, leading to a 3.7% increase in the Zacks Consensus Estimate [12] Group 2 - INSP holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - There is a strong correlation between trends in earnings estimate revisions and near-term stock price movements, supporting the expectation of an upside in INSP [11] - Analysts' price targets, while often overly optimistic, can provide a starting point for further research into the stock's potential [9][10]

Shares of Nomad Foods (NOMD) have gained 6.3% over the past four weeks to close the last trading session at $20, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $25 indicates a potential upside of 25%.The mean estimate comprises six short-term price targets with a standard deviation of $1.41. While the lowest estimate of $23 indicates a 15% increase from the current price level, ...

Shares of Coeur Mining (CDE) have gained 9.3% over the past four weeks to close the last trading session at $5.31, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $9.22 indicates a potential upside of 73.6%.The average comprises nine short-term price targets ranging from a low of $7 to a high of $11, with a standard deviation of $1.18. While the lowest estimate indicates an incr ...

Shares of ZipRecruiter, Inc. (ZIP) have gained 5.8% over the past four weeks to close the last trading session at $5.51, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $8.40 indicates a potential upside of 52.5%.The average comprises five short-term price targets ranging from a low of $7 to a high of $10, with a standard deviation of $1.52. While the lowest estimate indicates a ...

Shares of Equinox Gold (EQX) have gained 4.3% over the past four weeks to close the last trading session at $6.27, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $8.10 indicates a potential upside of 29.2%.The mean estimate comprises eight short-term price targets with a standard deviation of $1.39. While the lowest estimate of $6.66 indicates a 6.2% increase from the current p ...

Core Viewpoint - Pan American Silver (PAAS) shows significant upside potential with a mean price target of $31.35, indicating a 33.2% increase from its current price of $23.54 [1] Price Targets and Analyst Estimates - The mean estimate consists of nine short-term price targets with a standard deviation of $3.78, suggesting variability in analyst predictions [2] - The lowest estimate of $27.36 indicates a 16.2% increase, while the highest estimate suggests a potential surge of 61.4% to $38 [2] - A low standard deviation among price targets indicates a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Sentiment - Analysts are optimistic about PAAS's earnings prospects, as indicated by a positive trend in earnings estimate revisions [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has increased by 10.2%, with four estimates moving higher and three lower [12] - PAAS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be wise, as analysts' ability to set accurate targets has been questioned [3][10] - Analysts often set overly optimistic price targets due to business incentives, which can lead to inflated expectations [8]

Group 1 - First Majestic Silver (AG) shares have increased by 5.9% over the past four weeks, closing at $5.91, with a mean price target of $7.89 indicating a potential upside of 33.5% [1] - The average price targets range from a low of $6 to a high of $11, with a standard deviation of $1.87, suggesting variability in analyst estimates [2] - Analysts have shown a strong agreement in revising earnings estimates higher, with the Zacks Consensus Estimate for the current year increasing by 16.7% over the past month [11][12] Group 2 - AG holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - The correlation between earnings estimate revisions and near-term stock price movements supports the expectation of a potential upside for AG [11] - While price targets can be misleading, the direction implied by the consensus price target suggests a positive outlook for AG [10][13]